A breakthrough for ALS research — the FDA has approved VectorYs’ trial aimed at TDP-43, opening the door to new treatment possibilities. Details: https://f.mtr.cool/amhpwfmzeb #amyotrophiclateralsclerosis #louggehrigdisease #als #drugtrials

A breakthrough for ALS research — the FDA has approved VectorYs’ trial aimed at TDP-43, opening the door to new treatment possibilities. Details: https://f.mtr.cool/amhpwfmzeb #amyotrophiclateralsclerosis #louggehrigdisease #als #drugtrials

Original post on masto.ai

How #PrivateEquity Oversees the #Ethics of #DrugResearch

Many #DrugTrials are vetted by companies with ties to the #drugmakers, raising concerns about #ConflictsOfInterest & #patient #safety.

#law #PublicHealth […]

Roche’s COPD drug shows mixed results in late-stage trials Investing.com -- Roche Holding AG (OTC:RHHVF) on Monday reported mixed results from late-stage trials for its experimental drug astegolimab, which is being developed to treat chronic obstructive pulmonary disease (COPD). According to a statement released Monday, the drug showed a 15.4% reduction in worsening of the condition, known as exacerbations, in a phase 2b study. However, astegolimab failed to meet its goal in another trial. Levi Garraway, Roche’s chief medical officer and head of global product development, said: "This was the first set of studies in an ’all-comers’ COPD population, and we will discuss these data with regulatory authorities to evaluate next steps for astegolimab." The mixed results represent a setback for the company as it works to accelerate the development of new treatments for the deadly lung condition. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Before you buy stock in ROG, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is ROG one of them?

Click Subscribe #Roche #COPD #DrugTrials #Healthcare #Pharmaceuticals

Whatever happened to those people whose skin fell off during the #drugtrials years ago?

Under Biden, America led the world in drug trials. Now China leads the world in drug trials. #trump #GOP #drugtrials #medicine

Key concern about the new pill: potential side effects. Users specifically mentioned worries about increased heart rate and blood pressure seen in trials. Safety is paramount. #DrugTrials 3/6

Public Comment of National Center for Health Research Regarding Accelerated Approval and Considerations for Determining Whether a Confirmatory Trial is Underway - National Center for Health Research March 10, 2025: National Center for Health Research supports FDA's decision to require that a confirmatory trial is "underway" before granting accelerated approval, but the definition of underway need...

NCHR urges the FDA to strengthen its draft guidance on accelerated approval confirmatory trials, using concrete metrics of when a confirmatory trial is "underway." #FDA #drugtrials #acceleratedapproval #MedSky
Read more: www.center4research.org/nchr-fda-con...

AI-Driven Drug Clinical Trials by Year End, Says Google's Hassabis - Neurospan Isomorphic Labs, the four-year-old drug discovery start-up owned by Alphabet, is poised to achieve a significant milestone in artificial intelligence […]

neurospan.org/ai-driven-dr...
#drugtrials